𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pilot study of recombinant human granulocyte-macrophage colony–stimulating factor in the treatment of chronic hepatitis B

✍ Scribed by Julio Martin; Orencio Bosch; Gloria Moraleda; Javier Bartolome; Juan Antonio Quiroga; Dr. Vicente Carreño

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
593 KB
Volume
18
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis

is a fellow of Ministerio de Educaci6n y Ciencia. J. Bartolome and J.A. Quiroga are recipients of research grants from Fundacion para el Estudio de las Hepatitis Vudes.

📜 SIMILAR VOLUMES

Recombinant human granulocyte-colony sti
Recombinant human granulocyte-colony stimulating factor and recombinant human macrophage colony stimulating factor synergize in vivo to enhance proliferation of granulocyte-macrophage, erythroid, and multipotential progenitor cells in mice
✍ Hal E. Broxmeyer; Douglas E. Williams; Scott Cooper; Giao Hangoc; Peter Ralph 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

Combinations of low dosages of purified recombinant human (rh) macrophagecolony stimulating factor (M-CSF; also termed CSF-1) and rh granulocyte-colony stimulating factor (G-CSF) were compared alone and in combination for their influence on the cycling rates and numbers of bone marrow and splenic gr

Treatment of severe aplastic anemia with
Treatment of severe aplastic anemia with an immunosuppressive agent plus recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin
✍ Zonghong Shao; Yulin Chu; Yizhi Zhang; Guibin Chen; Yizhou Zheng 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

To evaluate the therapeutic potential of hematopoietic growth factors (HGFs) during immunosuppressive treatment (IST) of severe aplastic anemia (SAA), 38 patients with newly diagnosed SAA received IST alone (group I), or IST plus recombinant human erythropoietin and granulocyte-macrophage colony-sti

Treatment of de novo acute myelogenous l
Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: Effect of granulocyte macrophage-colony-stimulating factor on white blood cell counts
✍ Valent, Peter ;Sillaber, Christian ;Geissler, Klaus ;Andreeff, Michael ;Tafuri, 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

GM-CSF is a major regulator of myelopoiesis. Recombinant human GM-CSF (250 micrograms/m2 per day i.v.) was used prior to chemotherapy ("3 + 7" scheme) to recruit leukemic blasts in vivo (de novo AML patients, n = 20) into the chemotherapy sensitive phases of the cell cycle. The stimulatory effect of

Effect of recombinant human granulocyte
Effect of recombinant human granulocyte macrophage-colony stimulating factor in long-term marrow cultures from patients with aplastic anemia
✍ Mart�nez-Jaramillo, Guadalupe; G�mez-Morales, Enrique; Mayani, Hector 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

The hematopoietic system in patients with aplastic anemia (AA) shows both quantitative and qualitative deficiencies, i.e., reduced numbers of hematopoietic progenitor cells (HPC) and impaired HPC proliferation in long-term marrow cultures (LTMC). Since recombinant human granulocyte macrophage-colony